Country: Canada
Language: English
Source: Health Canada
MICAFUNGIN (MICAFUNGIN SODIUM)
JUNO PHARMACEUTICALS CORP.
J02AX05
MICAFUNGIN
50MG
POWDER FOR SOLUTION
MICAFUNGIN (MICAFUNGIN SODIUM) 50MG
INTRAVENOUS
15G/50G
Prescription
Active ingredient group (AIG) number: 0163379001; AHFS:
APPROVED
2022-02-04
_Product Monograph - Micafungin Sodium for Injection_ _ _ Page 1 of 39_ _ PRODUCT MONOGRAPH PR MICAFUNGIN SODIUM FOR INJECTION 50 mg and 100 mg micafungin (as micafungin sodium) per vial Sterile Powder for Injection Antifungal Juno Pharmaceuticals Corp. 402-2233 Argentia Road, Mississauga, ON L5N 2X7 CONTROL NUMBER: 240052 Date of Preparation: February 04, 2022 _Product Monograph - Micafungin Sodium for Injection_ _ _ Page 2 of 39_ _ _Product Monograph - Micafungin Sodium for Injection_ _ _ Page 3 of 39_ _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 4 SUMMARY PRODUCT INFORMATION ................................................................................... 4 INDICATIONS AND CLINICAL USE ......................................................................................... 4 CONTRAINDICATIONS .............................................................................................................. 5 WARNINGS AND PRECAUTIONS ............................................................................................. 5 ADVERSE REACTIONS ............................................................................................................... 7 DRUG INTERACTIONS ............................................................................................................. 13 DOSAGE AND ADMINISTRATION ......................................................................................... 14 OVERDOSAGE ........................................................................................................................... 17 ACTION AND CLINICAL PHARMACOLOGY ....................................................................... 18 STORAGE AND STABILITY ..................................................................................................... 21 SPECIAL HANDLING INSTRUCTIONS .................................................................................. 21 DOSAGE FORMS, COMPOSITION AND PACKAGING .................... Read the complete document